Alterity Therapeutics Limited
ATHE
$3.48
$0.030.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.45M | -8.64M | -7.89M | -10.46M | -13.05M |
| Total Depreciation and Amortization | 80.50K | 85.20K | 90.60K | 93.40K | 96.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.25M | 762.30K | 728.10K | 696.50K |
| Change in Net Operating Assets | -1.29M | -857.50K | -443.00K | 469.90K | 1.39M |
| Cash from Operations | -8.92M | -8.16M | -7.48M | -9.17M | -10.86M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 160.20K | -2.30M | -4.75M | -2.35M | -- |
| Cash from Investing | 160.20K | -2.30M | -4.75M | -2.35M | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.00K | -126.00K | -127.00K | -75.40K | -23.80K |
| Issuance of Common Stock | 62.55M | 52.56M | 42.57M | 25.87M | 9.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.85M | -3.31M | -2.77M | -1.73M | -686.60K |
| Cash from Financing | 37.54M | 31.34M | 25.16M | 15.24M | 5.57M |
| Foreign Exchange rate Adjustments | -125.10K | -125.80K | -126.90K | 10.30K | 146.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.66M | 20.75M | 12.79M | 3.73M | -5.14M |